Elevance Health Stock Performance
| ELV Stock | USD 341.85 18.93 5.86% |
Elevance Health has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.62, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Elevance Health will likely underperform. Elevance Health right now shows a risk of 2.69%. Please confirm Elevance Health value at risk, and the relationship between the jensen alpha and skewness , to decide if Elevance Health will be following its price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Elevance Health are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady essential indicators, Elevance Health may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Actual Historical Performance (%)
One Day Return 5.86 | Five Day Return (7.71) | Year To Date Return (3.50) | Ten Year Return 161.97 | All Time Return 1.6 K |
Forward Dividend Yield 0.0212 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 6.84 | Dividend Date 2025-12-19 |
1 | National Bank of Canada FI Reduces Holdings in Elevance Health, Inc. ELV | 12/15/2025 |
| Elevance Health dividend paid on 19th of December 2025 | 12/19/2025 |
2 | DAVENPORT Co LLC Boosts Stock Position in Elevance Health, Inc. ELV - MarketBeat | 12/24/2025 |
3 | Acquisition by Felicia Norwood of 3035 shares of Elevance Health subject to Rule 16b-3 | 01/09/2026 |
4 | Mizuho Raises Elevance Health PT to 413 Citing Peaking Healthcare Utilization Growth | 01/14/2026 |
5 | GOG Boss Says We May Get Fewer Games If Regulators Force Devs To Maintain Them Forever | 01/15/2026 |
6 | Wheelhouse Advisory Group LLC Acquires New Holdings in Elevance Health, Inc. ELV | 01/16/2026 |
7 | 2 Reasons to Watch ELV and 1 to Stay Cautious | 01/21/2026 |
8 | Health insurers tumble after Trump administration proposes keeping Medicare Advantage rates flat next year | 01/26/2026 |
9 | Kid Cudi announces Rebel Ragers Tour, MSG show. Get tickets today | 01/27/2026 |
| Begin Period Cash Flow | 8.3 B | |
| Total Cashflows From Investing Activities | -1.3 B |
Elevance Health Relative Risk vs. Return Landscape
If you would invest 31,557 in Elevance Health on October 31, 2025 and sell it today you would earn a total of 2,628 from holding Elevance Health or generate 8.33% return on investment over 90 days. Elevance Health is generating 0.1707% of daily returns assuming volatility of 2.6928% on return distribution over 90 days investment horizon. In other words, 24% of stocks are less volatile than Elevance, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Elevance Health Target Price Odds to finish over Current Price
The tendency of Elevance Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 341.85 | 90 days | 341.85 | about 50.4 |
Based on a normal probability distribution, the odds of Elevance Health to move above the current price in 90 days from now is about 50.4 (This Elevance Health probability density function shows the probability of Elevance Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.62 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Elevance Health will likely underperform. Additionally Elevance Health has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Elevance Health Price Density |
| Price |
Predictive Modules for Elevance Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Elevance Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Elevance Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Elevance Health is not an exception. The market had few large corrections towards the Elevance Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Elevance Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Elevance Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.09 | |
β | Beta against Dow Jones | 1.62 | |
σ | Overall volatility | 20.75 | |
Ir | Information ratio | -0.02 |
Elevance Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Elevance Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Elevance Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| On 19th of December 2025 Elevance Health paid $ 1.71 per share dividend to its current shareholders | |
| Latest headline from globenewswire.com: 4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players |
Elevance Health Fundamentals Growth
Elevance Stock prices reflect investors' perceptions of the future prospects and financial health of Elevance Health, and Elevance Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Elevance Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0424 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 95.15 B | ||||
| Shares Outstanding | 222.24 M | ||||
| Price To Earning | 19.27 X | ||||
| Price To Book | 1.63 X | ||||
| Price To Sales | 0.37 X | ||||
| Revenue | 198.69 B | ||||
| Gross Profit | 51.16 B | ||||
| EBITDA | 9.57 B | ||||
| Net Income | 5.66 B | ||||
| Cash And Equivalents | 8.29 B | ||||
| Cash Per Share | 150.32 X | ||||
| Total Debt | 31.23 B | ||||
| Debt To Equity | 0.66 % | ||||
| Current Ratio | 1.35 X | ||||
| Book Value Per Share | 197.95 X | ||||
| Cash Flow From Operations | 4.29 B | ||||
| Earnings Per Share | 24.54 X | ||||
| Market Capitalization | 72.71 B | ||||
| Total Asset | 116.89 B | ||||
| Retained Earnings | 33.55 B | ||||
About Elevance Health Performance
Evaluating Elevance Health's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Elevance Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Elevance Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.06 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.05 | 0.04 | |
| Return On Equity | 0.13 | 0.10 |
Things to note about Elevance Health performance evaluation
Checking the ongoing alerts about Elevance Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Elevance Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| On 19th of December 2025 Elevance Health paid $ 1.71 per share dividend to its current shareholders | |
| Latest headline from globenewswire.com: 4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players |
- Analyzing Elevance Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Elevance Health's stock is overvalued or undervalued compared to its peers.
- Examining Elevance Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Elevance Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Elevance Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Elevance Health's stock. These opinions can provide insight into Elevance Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.